Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
United States
Collaborative Neuroscience Network - CNS, Los Alamitos, California ICON Early Phase Services, San Antonio, Texas Singapore
Lilly Centre for Clinical Pharmacology, Singapore